Graf Acquisition IV, NKGen Biotech Announce Letter Of Intent For Business Combination
$GFOR
Blank Checks
Finance
Graf Acquisition IV, NKGen Biotech Announce Letter Of Intent For Business Combination
Save time and jump to the most important pieces.
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 20, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 25, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. The Company has decided to adjourn the Special M
THE WOODLANDS, Texas, Sept. 14, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 13, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 10:00 a.m., Eastern time, on September 20, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has recei
THE WOODLANDS, Texas, Sept. 11, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 8, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 13, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has receive
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
SC 13G - NKGen Biotech, Inc. (0001845459) (Subject)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
During Thursday's session, 406 companies made new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE). The smallest company by market cap to set a new 52-week low was Ascent Solar Technologies (NASDAQ:ASTI). Ascent Solar Technologies (NASDAQ:ASTI)'s stock fell the most, as it traded down 62.52% to reach a new 52-week low. Nuveen Pennsylvania (NYSE:NQP)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low. Stocks that set new 52-week lows on Thursday are as follows: Pfizer (NYSE:PFE) stock hit $31.77 on Thursday morning, setting a new 52-week low for a change of do